In contrast, after accounting for multiple testing, variants in the APOE and CETP gene regions were associated with AMD risk, suggesting that lowering APOE may decrease AMD risk and that inhibiting CETP to increase HDL-cholesterol levels may increase AMD risk. The gene discussed is APOE; the disease is age-related macular degeneration.